Extended panels may include barbiturates, benzodiazepines, methadone, and synthetic opioids, but these remain focused on substances with abuse potential or regulatory significance
Our work sets the highest standards in endocrine care.
(For the record, Millennials are using GLP-1s quite a bit as well.) This may make sense, given that the older you get, the harder it can be to lose weight
Pfizer and Novo Nordisk engaged in a high-profile tussle over the acquisition of Metsera, an obesity and cardiometabolic clinical-stage biotech, highlighting the strategic value attributed to innovative pipelines in an increasingly crowded field
Medical Evaluation When appropriate, we assess relevant health markers to ensure this peptide combination is safe and appropriate for your needs
Speak to a healthcare professional before considering any unlicensed peptide or Retatrutide stack, particularly if you have diabetes, cardiovascular disease or another long-term medical condition